Wang, Lingshu
Shi, Wei
Joyce, M. Gordon
Modjarrad, Kayvon
Zhang, Yi
Leung, Kwanyee
Lees, Christopher R.
Zhou, Tongqing
Yassine, Hadi M.
Kanekiyo, Masaru
Yang, Zhi-yong
Chen, Xuejun
Becker, Michelle M.
Freeman, Megan
Vogel, Leatrice
Johnson, Joshua C.
Olinger, Gene
Todd, John P.
Bagci, Ulas
Solomon, Jeffrey
Mollura, Daniel J.
Hensley, Lisa
Jahrling, Peter
Denison, Mark R.
Rao, Srinivas S.
Subbarao, Kanta
Kwong, Peter D.
Mascola, John R.
Kong, Wing-Pui
Graham, Barney S.
Article History
Received: 21 April 2015
Accepted: 3 June 2015
First Online: 28 July 2015
Competing interests
: L.W., W.S., M.G.J., K.M., P.D.K., J.R.M., W.P.K. and B.S.G. are inventors on a U.S. patent application describing the use of Spike glycoprotein as a vaccine antigen and monoclonal antibodies D12, F11, G2, G4 as potential therapeutics and aids in vaccine design.